Gilead Sciences wonder drug showing promise in the COVID-19 battle

Gilead Sciences (NASDAQ:GILD) has made promising progress in the treatment of COVID-19 with their drug Remdesivir. The US Bio-tech giant conducted a trial with 53 patients with COVID-19 in the US, Canada and Europe. All 53 patients were considered to have severe complications due to the virus, all needing respiratory support. “The majority of patients …